A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang… - Nature biomedical …, 2021 - nature.com
The rapid repurposing of antivirals is particularly pressing during pandemics. However,
rapid assays for assessing candidate drugs typically involve in vitro screens and cell lines …

[PDF][PDF] Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics

L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang, A Nurani… - BioRxiv, 2020 - academia.edu
Rapidly spreading viral pandemics, such as those caused by influenza and SAR-CoV-2
(COVID19), require rapid action and the fastest way to combat this challenge is by …

High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro

AL Gard, RJ Luu, CR Miller, R Maloney, BP Cain… - Scientific reports, 2021 - nature.com
Influenza and other respiratory viruses present a significant threat to public health, national
security, and the world economy, and can lead to the emergence of global pandemics such …

Microfluidic organs-on-a-chip for modeling human infectious diseases

Y Wang, P Wang, J Qin - Accounts of Chemical Research, 2021 - ACS Publications
Conspectus Infectious diseases present tremendous challenges to human progress and
public health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS …

Development of human-derived, three-dimensional respiratory epithelial tissue constructs with perfusable microvasculature on a high-throughput microfluidics …

O Jung, YT Tung, E Sim, YC Chen, E Lee… - …, 2022 - iopscience.iop.org
The COVID-19 pandemic has highlighted the need for human respiratory tract-based assay
platforms for efficient discovery and development of antivirals and disease-modulating …

[PDF][PDF] SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming

CT Wu, PV Lidsky, Y Xiao, R Cheng, IT Lee… - Cell, 2023 - cell.com
How SARS-CoV-2 penetrates the airway barrier of mucus and periciliary mucins to infect
nasal epithelium remains unclear. Using primary nasal epithelial organoid cultures, we …

Microfluidic organ-chips and stem cell models in the fight against COVID-19

S Satta, SJ Rockwood, K Wang, S Wang… - Circulation …, 2023 - Am Heart Assoc
SARS-CoV-2, the virus underlying COVID-19, has now been recognized to cause
multiorgan disease with a systemic effect on the host. To effectively combat SARS-CoV-2 …

Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes

NG Ravindra, MM Alfajaro, V Gasque, NC Huston… - PLoS …, 2021 - journals.plos.org
There are currently limited Food and Drug Administration (FDA)-approved drugs and
vaccines for the treatment or prevention of Coronavirus Disease 2019 (COVID-19) …

In vitro lung models and their application to study SARS-CoV-2 pathogenesis and disease

N Heinen, M Klöhn, E Steinmann, S Pfaender - Viruses, 2021 - mdpi.com
SARS-CoV-2 has spread across the globe with an astonishing velocity and lethality that has
put scientist and pharmaceutical companies worldwide on the spot to develop novel …

The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory …

A Rajan, AM Weaver, GM Aloisio, J Jelinski… - MBio, 2022 - Am Soc Microbiol
There is an unmet need for preclinical models to understand the pathogenesis of human
respiratory viruses and predict responsiveness to immunotherapies. Airway organoids can …